Literature DB >> 25802024

Report of the second Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-2) international workshop San Sebastian, Spain, October 16, 2013.

Cynthia Gagnon1, Giovanni Meola2, Luc J Hébert3, Luc Laberge4, Mario Leone5, Chad Heatwole6.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25802024     DOI： 10.1016/j.nmd.2015.01.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  11 in total

1.  Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.

Authors:  Marie-Pier Roussel; Marie-Michèle Fiset; Laurie Gauthier; Claudia Lavoie; Émilie McNicoll; Laurie Pouliot; Cynthia Gagnon; Elise Duchesne
Journal:  J Neurol       Date:  2021-04-27       Impact factor: 4.849

2.  Patient-Centered Core Impact Sets: What They are and Why We Need Them.

Authors:  Eleanor M Perfetto; Elisabeth M Oehrlein; T Rosie Love; Silke Schoch; Annie Kennedy; Jennifer Bright
Journal:  Patient       Date:  2022-06-02       Impact factor: 3.481

3.  Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).

Authors:  Giovanni DiPaolo; Cecilia Jimenez-Moreno; Nikoletta Nikolenko; Antonio Atalaia; Darren G Monckton; Michela Guglieri; Hanns Lochmüller
Journal:  J Neurol       Date:  2017-02-06       Impact factor: 4.849

4.  Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.

Authors:  Carla Gliem; Martina Minnerop; Sandra Roeske; Hanna Gärtner; Jan-Christoph Schoene-Bake; Sandra Adler; Juri-Alexander Witt; Felix Hoffstaedter; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Katrin Amunts; Thomas Klockgether; Bernd Weber; Cornelia Kornblum
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

5.  Analysis of the functional capacity outcome measures for myotonic dystrophy.

Authors:  Aura Cecilia Jimenez-Moreno; Nikoletta Nikolenko; Marie Kierkegaard; Alasdair P Blain; Jane Newman; Charlotte Massey; Dionne Moat; Jas Sodhi; Antonio Atalaia; Grainne S Gorman; Chris Turner; Hanns Lochmüller
Journal:  Ann Clin Transl Neurol       Date:  2019-07-22       Impact factor: 4.511

6.  Brain Structural Features of Myotonic Dystrophy Type 1 and their Relationship with CTG Repeats.

Authors:  Ellen van der Plas; Mark J Hamilton; Jacob N Miller; Timothy R Koscik; Jeffrey D Long; Sarah Cumming; Julija Povilaikaite; Maria Elena Farrugia; John McLean; Ravi Jampana; Vincent A Magnotta; Laurie Gutmann; Darren G Monckton; Peggy C Nopoulos
Journal:  J Neuromuscul Dis       Date:  2019

7.  Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease.

Authors:  Libby Wood; Guillaume Bassez; Corinne Bleyenheuft; Craig Campbell; Louise Cossette; Aura Cecilia Jimenez-Moreno; Yi Dai; Hugh Dawkins; Jorge Alberto Diaz Manera; Celine Dogan; Rasha El Sherif; Barbara Fossati; Caroline Graham; James Hilbert; Kristinia Kastreva; En Kimura; Lawrence Korngut; Anna Kostera-Pruszczyk; Christopher Lindberg; Bjorn Lindvall; Elizabeth Luebbe; Anna Lusakowska; Radim Mazanec; Giovani Meola; Liannna Orlando; Masanori P Takahashi; Stojan Peric; Jack Puymirat; Vidosava Rakocevic-Stojanovic; Miriam Rodrigues; Richard Roxburgh; Benedikt Schoser; Sonia Segovia; Andriy Shatillo; Simone Thiele; Ivailo Tournev; Baziel van Engelen; Stanislav Vohanka; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2018-09-05       Impact factor: 4.123

8.  Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

Authors:  Edward Callus; Enrico G Bertoldo; Maria Beretta; Sara Boveri; Rosanna Cardani; Barbara Fossati; Elisa Brigonzi; Giovanni Meola
Journal:  Front Neurol       Date:  2018-09-19       Impact factor: 4.003

9.  Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight.

Authors:  Mark J Hamilton; John McLean; Sarah Cumming; Bob Ballantyne; Josephine McGhie; Ravi Jampana; Cheryl Longman; Jonathan J Evans; Darren G Monckton; Maria Elena Farrugia
Journal:  Front Neurol       Date:  2018-10-02       Impact factor: 4.003

10.  Responsiveness of outcome measures in myotonic dystrophy type 1.

Authors:  Kirsten L Knak; Aisha M Sheikh; Nanna Witting; John Vissing
Journal:  Ann Clin Transl Neurol       Date:  2020-07-16       Impact factor: 4.511
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.